NCT02389582View on ClinicalTrials.gov

Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Coronary Disease
Interventions
DRUG

Dabigatran

Use for 5 days

DRUG

Enoxaparin

Use for 5 days

Trial Locations (1)

Unknown

InCor Heart Institute, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo General Hospital

OTHER

NCT02389582 - Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease | Biotech Hunter | Biotech Hunter